John H Johnson Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John H Johnson.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John H Johnson. John H Johnson is a CEO in IMCLONE SYSTEMS INC ($IMCLE) and a Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and a Director in AVEO PHARMACEUTICALS INC ($AVEO) and a Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Director in HISTOGENICS CORP ($HSGX) and an Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and a Director in CEMPRA, INC. ($CEMP) and a Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and a Director in Verastem, Inc. ($VSTM) and an Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and a Director in Strongbridge Biopharma plc ($SBBP) and an Executive Chairman in Strongbridge Biopharma plc ($SBBP).

Address: IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET NEW YORK 10014 NY

Companies in which John H Johnson is an Insider

AVEO PHARMACEUTICALS, INC.

Trading Symbol: AVEO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 05 2018
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IMCLONE SYSTEMS INC

Trading Symbol: IMCLE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John H Johnson: CEO
Holdings: 0 shares
Latest Transaction: Nov 26 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MELINTA THERAPEUTICS, INC. /NEW/

Trading Symbol: MLNT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Chief Executive Officer, Interim CEO, Director
Holdings: 37,400 shares
Current Value: $112,200
Latest Transaction: Jul 02 2019
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ocugen, Inc.

Trading Symbol: HSGX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PORTOLA PHARMACEUTICALS INC

Trading Symbol: PTLA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Strongbridge Biopharma plc

Trading Symbol: SBBP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Chief Executive Officer, Executive Chairman, Director
Holdings: 995,827 shares
Latest Transaction: Apr 09 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sucampo Pharmaceuticals, Inc.

Trading Symbol: SCMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Verastem, Inc.

Trading Symbol: VSTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of John H Johnson

Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 09 2021	SBBP	Strongbridge Bioph ...	JOHNSON JOHN	Chief Executive Off ...	Payment of Exercise	F	2.68	17,325	46,431	995,827	1 M to 995.8 K (-1.71 %)
Jul 07 2020	SBBP	Strongbridge Bioph ...	JOHNSON JOHN	Chief Executive Off ...	Grant	A	0.00	315,000	0	522,152	207.2 K to 522.2 K (+152.06 %)
Jul 02 2020	PTLA	PORTOLA PHARMACEUT ...	JOHNSON JOHN	Director	Option Exercise	D	0.00	54,991	0	0
Jul 02 2020	PTLA	PORTOLA PHARMACEUT ...	JOHNSON JOHN	Director	Option Exercise	D	17.94	11,377	204,103	0
Jul 02 2020	PTLA	PORTOLA PHARMACEUT ...	JOHNSON JOHN	Director	Sell	D	18.00	7,281	131,058	0	7.3 K to 0 (-100.00 %)
Jul 02 2020	PTLA	PORTOLA PHARMACEUT ...	JOHNSON JOHN	Director	Sell	D	18.00	13,194	237,492	0	13.2 K to 0 (-100.00 %)
Jun 18 2020	VSTM	Verastem, Inc.	JOHNSON JOHN	Director	Option Exercise	A	1.77	27,602	48,856	27,602

View all John H Johnson insider transactions.